Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 9 | 2025 | 3626 | 1.650 |
Why?
|
DNA, Mitochondrial | 2 | 2024 | 871 | 1.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5716 | 1.200 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2022 | 134 | 0.710 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4835 | 0.630 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2024 | 658 | 0.620 |
Why?
|
Adoptive Transfer | 1 | 2020 | 824 | 0.570 |
Why?
|
Leukemia | 2 | 2024 | 1520 | 0.570 |
Why?
|
T-Lymphocytes | 6 | 2024 | 10276 | 0.530 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 1399 | 0.520 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2542 | 0.520 |
Why?
|
Anemia, Aplastic | 1 | 2018 | 231 | 0.520 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 210 | 0.450 |
Why?
|
Bone Marrow | 5 | 2025 | 2935 | 0.440 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 1642 | 0.440 |
Why?
|
F-Box Proteins | 1 | 2015 | 201 | 0.420 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 2001 | 0.390 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3671 | 0.370 |
Why?
|
Flow Cytometry | 2 | 2019 | 5905 | 0.360 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1281 | 0.360 |
Why?
|
Hematologic Neoplasms | 2 | 2020 | 1907 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4651 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3608 | 0.320 |
Why?
|
Neuroblastoma | 1 | 2015 | 1266 | 0.270 |
Why?
|
Clone Cells | 2 | 2021 | 1670 | 0.270 |
Why?
|
Mutation | 3 | 2024 | 30266 | 0.240 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3724 | 0.230 |
Why?
|
Cell Separation | 2 | 2019 | 1728 | 0.210 |
Why?
|
Tumor Microenvironment | 3 | 2025 | 3951 | 0.210 |
Why?
|
Phenotype | 5 | 2024 | 16735 | 0.200 |
Why?
|
Recurrence | 3 | 2023 | 8512 | 0.190 |
Why?
|
Cell Tracking | 1 | 2022 | 140 | 0.180 |
Why?
|
DNA Methylation | 1 | 2015 | 4432 | 0.180 |
Why?
|
Chromatin | 2 | 2023 | 2981 | 0.180 |
Why?
|
Leukemia, Myeloid | 1 | 2021 | 693 | 0.150 |
Why?
|
Allergy and Immunology | 1 | 2019 | 175 | 0.150 |
Why?
|
Immunophenotyping | 1 | 2022 | 1866 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1082 | 0.130 |
Why?
|
Humans | 24 | 2025 | 768887 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1418 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1376 | 0.120 |
Why?
|
Cell Lineage | 2 | 2022 | 2576 | 0.120 |
Why?
|
Phthalimides | 1 | 2015 | 34 | 0.120 |
Why?
|
Naphthoquinones | 1 | 2015 | 59 | 0.120 |
Why?
|
Tissue Donors | 1 | 2024 | 2382 | 0.120 |
Why?
|
Aminoquinolines | 1 | 2015 | 105 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1855 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2909 | 0.110 |
Why?
|
Immunoglobulins | 1 | 2017 | 855 | 0.110 |
Why?
|
Neoplasms | 1 | 2023 | 22390 | 0.110 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2055 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1437 | 0.100 |
Why?
|
Tryptophan | 1 | 2015 | 482 | 0.100 |
Why?
|
B-Lymphocytes | 3 | 2024 | 4794 | 0.100 |
Why?
|
Multiple Myeloma | 2 | 2022 | 5195 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1560 | 0.100 |
Why?
|
Cell Proliferation | 2 | 2018 | 10486 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1762 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4413 | 0.080 |
Why?
|
Mitochondria | 1 | 2023 | 3683 | 0.080 |
Why?
|
Genotype | 1 | 2024 | 13048 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2931 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1277 | 0.080 |
Why?
|
Doxorubicin | 1 | 2015 | 2234 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9549 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1893 | 0.070 |
Why?
|
Pyrimidines | 2 | 2015 | 3050 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3433 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2015 | 4291 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4919 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 2029 | 0.060 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.060 |
Why?
|
Animals | 5 | 2024 | 169408 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 2574 | 0.050 |
Why?
|
Mice | 4 | 2024 | 82074 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 3048 | 0.050 |
Why?
|
Receptors, Complement 3d | 1 | 2022 | 117 | 0.050 |
Why?
|
HLA-A Antigens | 1 | 2022 | 223 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 336 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13699 | 0.040 |
Why?
|
Female | 7 | 2025 | 397464 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5342 | 0.040 |
Why?
|
Male | 6 | 2025 | 365249 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11886 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 812 | 0.040 |
Why?
|
Oncogenes | 1 | 2024 | 1236 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17174 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2025 | 1803 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3283 | 0.040 |
Why?
|
Middle Aged | 4 | 2025 | 223740 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2529 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1735 | 0.030 |
Why?
|
Janus Kinases | 1 | 2015 | 253 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3554 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2884 | 0.030 |
Why?
|
Adult | 2 | 2024 | 223818 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 990 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3214 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5800 | 0.020 |
Why?
|
Immunotherapy | 1 | 2025 | 4755 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14485 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22294 | 0.020 |
Why?
|
Infant | 1 | 2024 | 36541 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42684 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12873 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11262 | 0.010 |
Why?
|
Child | 1 | 2024 | 80969 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 89247 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18366 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 30044 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39394 | 0.010 |
Why?
|
Aged | 2 | 2017 | 171790 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 60110 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2015 | 81892 | 0.000 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(55)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_